Ginkgo Bioworks Holdings Inc 's ability to collect accounts receivable sequentially worsen to 218.58, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Average collection period, for Ginkgo Bioworks Holdings Inc 's accounts receivable remained unchanged at 2 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 2 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 24, from overall ranking in the fourth quarter 2025 at 1965.

What is Receivable Turnover Ratio?
What is Ginkgo Bioworks Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DNA Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-48.23 %	-60.92 %	74.95 %	222.52 %	137.03 %
Y / Y Revenue Change	-59.7 %	-23.84 %	-56.39 %	-11.75 %	27.34 %
Receivable Turnover Ratio (TTM)	218.58	226.19	214.62	311.07	413.62
DNA's Total Ranking	# 24	# 1965	# 2833	# 2682	# 16
Accounts Receivable average collection period days	2	2	2	1	1
Seq. Receivable Change	98.25 %	-75.35 %	-4.62 %	11.06 %	49.66 %
Seq. Revenue Change	-41.69 %	-14.01 %	-21.71 %	2.66 %	10.2 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 1
Healthcare Sector	# 3
Overall Market	# 24

Receivable Turnover Ratio Statistics
High	Average	Low
507.64	176.51	3.41
(Dec 31 2024)		(Mar 31 2023)

DNA Company Profile • Back to DNA Efficiency Comparisons • Compare DNA Receivables Turnover Ratio to its Competitors

Financial Statements
Ginkgo Bioworks Holdings Inc 's Accounts Receivable	$ 0 Millions	Visit DNA's Balance sheet
Ginkgo Bioworks Holdings Inc 's Sales TTM	$ 141 Millions	Visit DNA's Income Statement
Sources of DNA's Revenues		Visit DNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DNA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DNA's Growth Rates	DNA's Roa	DNA's Inventory Turnover Ratio	DNA's Dividend Comparisons
DNA's Profitability Ratios	DNA's Roi	DNA's Asset Turnover Ratio	DNA's Dividend Growth
DNA's Valuation Ratios	DNA's Roe	DNA's Financial Strength Ratios	DNA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Warby Parker Inc	486.16	$ 890.640 Millions	$ 1.832 Millions
Orchestra Biomed Holdings Inc	416.87	$ 32.724 Millions	$ 0.079 Millions
Iqvia Holdings Inc	408.15	$ 16,632.000 Millions	$ 40.750 Millions
Solana Company	408.04	$ 9.589 Millions	$ 0.024 Millions
Bausch Health Companies Inc	345.28	$ 10,531.000 Millions	$ 30.500 Millions
Logicmark Inc	284.46	$ 12.048 Millions	$ 0.042 Millions
Dr Reddy s Laboratories Limited	275.38	$ 3,580.000 Millions	$ 13.000 Millions
Ainos Inc	246.41	$ 0.018 Millions	$ 0.000 Millions
Ginkgo Bioworks Holdings Inc	218.58	$ 141.311 Millions	$ 0.647 Millions
Fortress Biotech Inc	192.61	$ 66.161 Millions	$ 0.344 Millions
Arcus Biosciences Inc	188.80	$ 236.000 Millions	$ 1.250 Millions
Immunocore Holdings Plc	186.94	$ 412.812 Millions	$ 2.208 Millions
Aclaris Therapeutics Inc	172.52	$ 8.367 Millions	$ 0.049 Millions
Hcw Biologics Inc	165.47	$ 6.592 Millions	$ 0.040 Millions
Prime Medicine Inc	134.47	$ 4.034 Millions	$ 0.030 Millions
Earth Science Tech Inc	127.94	$ 33.712 Millions	$ 0.263 Millions
Lenz Therapeutics Inc	124.93	$ 20.989 Millions	$ 0.168 Millions
Agape Atp Corporation	123.42	$ 1.509 Millions	$ 0.012 Millions
Assembly Biosciences Inc	121.69	$ 71.097 Millions	$ 0.584 Millions
Harvard Apparatus Regenerative Technology Inc	88.50	$ 0.885 Millions	$ 0.010 Millions
Zeo Scientifix Inc	74.53	$ 6.987 Millions	$ 0.094 Millions
Airsculpt Technologies Inc	69.52	$ 151.836 Millions	$ 2.184 Millions
Sbc Medical Group Holdings Incorporated	64.95	$ 167.536 Millions	$ 2.579 Millions
Arrowhead Pharmaceuticals Inc	63.74	$ 622.009 Millions	$ 9.758 Millions
Hims and Hers Health Inc	63.35	$ 2,369.476 Millions	$ 37.405 Millions

Date modified: 2026-08-30T15:01:25+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.